Arash Mostaghimi, MD, MPA, MPH, director of the inpatient dermatology consult service at Brigham & Women's Hospital, discusses the utility of deuruxolitinib for treating moderate to severe alopecia ...
Olumiant was cleared by the MHRA for severe alopecia in adults in 2022 ... including the scalp, eyelashes, and eyebrows. Lilly’s drug was turned down last October on the grounds that it was ...
Alopecia, a general term used to describe hair loss, impacts Black women disproportionately. Nearly half of all Black women will experience some form of hair loss in their lives. It can come in a ...